Company Overview and News
Gold prices dropped to a five-month low of $1,281.80 and closed at $1,283.30 per ounce yesterday, recording a one-day loss of 0.6% and a one-month loss of 3.3%. Silver joined the slump, dropping 0.8% to end the day at $16.30 per ounce, and platinum followed, falling 0.4% to end the day at $874 per ounce. Palladium was the only precious metal to see strength on Monday, rising 0.5% and ending the day at $960.
Although the markets have their own logic, highly capitalized gold-mining companies seemingly should belong on any “stocks to buy” list. Thanks to rising geopolitical tensions and soaring trading sentiment, many folks seek safe-haven assets. While gold stocks seemingly offer a viable solution, their overall performance has been unusually disappointing.
TMAC Resources Inc. (OTC:TMMFF) Q1 2018 Results Earnings Conference Call May 11, 2018 10:00 AM ET
Besides the rise and fall in the US dollar, another crucial factor affecting precious metals price changes is overall market volatility. Recently, when the United States withdrew from the Iran nuclear deal, the markets seemed to breathe a sigh of relief. Also, the geopolitical issues in the Korean Peninsula seem to have subsided. We also saw North Korea free three American detainees just ahead of talks between President Donald Trump and Kim Jong Un.
Precious metal mining companies typically follow precious metals. Precious metals seem to be in the doldrums over the strength of the US dollar and the Federal Reserve’s decision to raise interest rates several more times this year. The recent slump in the demand for haven assets has also affected mining stocks.
IAMGOLD (IAG) reported its 1Q18 results after the market closed on May 7. IAG reported EPS (earnings per share) of $0.09, beating the consensus estimate by $0.08. Its revenues also beat the consensus estimate by $14.0 million, coming in at $314.5 million.
Currently, there are many factors playing on gold prices, some of which are bullish while others are bearish. While bulls are taking cues from the recent geopolitical concerns stoked by trade tensions, the Syria attacks, and the whimsical policies of the current US administration, bears are taking solace from the rising US rate hike expectations.
In this final part of the series, we’ll look at the correlation between gold and four mining stocks: B2Gold (BTG), Royal Gold (RGLD), New Gold (NGD), and Newmont Mining (NEM). For the most part, mining stocks move with gold prices. Among these four miners, Newmont has shown the highest correlation with gold this year, while B2Gold has the lowest correlation year-to-date.
Good day. And welcome to the Royal Gold Fiscal 2018 Third Quarter Conference Call. All participants will be in listen-only mode [Operator Instructions]. After today’s presentation, there will be an opportunity to ask questions [Operator Instructions]. Please note this event is being recorded.
Yamana Gold’s (AUY) valuation multiple has varied widely between 4.3x and 9.8x over the last five years. Valuation multiples signify what investors are willing to pay for a stock based on analyst estimates. Yamana is currently trading at a forward EV-to-EBITDA (enterprise value to earnings before interest, tax, depreciation, and amortization) multiple of 5.6x.
Yamana Gold (AUY) released its 1Q18 earnings yesterday after the market closed. The company missed analysts’ consensus earnings per share (or EPS) estimate of $0.02, reporting adjusted EPS of $0.01. The company has a history of disappointing the markets with its weaker-than-expected results and inconsistent operational results. AUY’s 4Q17 results were also disappointing since the company reported a loss far below analysts’ expectations.
Rimfire Pacific Mining NL (ASX:RIM) has confirmed encouraging cobalt-nickel-scandium results from drilling at the Tout East prospect within its Fifield project in New South Wales.
In this part of our series, we’ll look at the correlation between gold and four mining stocks: New Gold (NGD), Newmont Mining (NEM), Sibanye Gold (SBGL), and Gold Fields (GFI).
April 26 (Reuters) - Canada’s main index rose higher on Thursday as financial stocks were lifted by Bank of Canada chief’s positive comments on the economy, while rising oil prices buoyed the energy sector.
The following slide deck was published by New Gold Inc in conjunction with their 2018 Q1 earnings call.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET